Medical Devices Series B Investors & VC Firms
515 firms in this list, with a median first check of $540K. 108 of them lead rounds. Generated from verified public data and updated continuously.
CDF-Capital
ShenzhenSeed–Late Stage
NIPPON EXPRESS HOLDINGS
Seed–Series B
Teewinot Ventures
Pre-Seed–Late Stage
Technology Venture Partners
MinneapolisSeed–Late Stage
3 people
MedVenture Health
Salt Lake CitySeed–Late Stage
5 people
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Olympus Innovation Ventures
Seed–Growth
2 people
Alliance Jura-Hongrie Venture Capital Fund Management
BudapestSeries A–Series B$324K – $2.8M
1 person
Alpha Ventures
AthensSeries A–Series B$1.6M – $10.8M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
FFG Venture Business Partners
FukuokaPre-Seed–Growth
1 person
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
Company K Partners
SeoulSeries A–Series B
Augere Venture
KrakówSeed–Late Stage
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
Brandon Capital Partners
MelbourneSeed–Growth
1 person
Chang'an Capital
BeijingSeed–Series B
3 people
CBC Group
SingaporeSeed–Late Stage
2 people
Pittsburgh Life Sciences Greenhouse
PittsburghSeed–Series B
1 person
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Woodford Investment Management
OxfordSeries A–Growth
Ippon
GenevaSeries A–Growth
1 person
Shanghai STVC Group
ShanghaiSeed–Growth
1 person
Related lists
Series B Investors & VC Firms (2954)Series B Investors & VC Firms in North America (1744)Medical Devices Investors & VC Firms (1659)Series B Investors & VC Firms in United States (1578)Medical Devices Seed Investors & VC Firms (1321)Medical Devices Series A Investors & VC Firms (1139)Medical Devices Investors & VC Firms in North America (1090)Series B Investors & VC Firms in Europe (1078)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Global (1068)
Data sourced from public filings and firms' own websites — see our methodology.








